Episode Details
Back to EpisodesMedicus Pharma ($MDCX) Chairman Discusses Promising Phase 2 SkinJect Results
Season 2026
Episode 816
Published 2 weeks, 2 days ago
Description
This interview is disseminated on behalf of Medicus Pharma Ltd.
In this episode of Stocks to Watch, we are joined by Medicus Pharma (NASDAQ: MDCX) Executive Chairman and CEO Dr. Raza Bokhari to discuss the company's promising Phase 2 results for SkinJect, its innovative skin cancer treatment, and what lies ahead for the company across oncology, rare diseases, and prostate cancer.
Learn more about Medicus Pharma: https://medicuspharma.com/
Watch the full YouTube interview here: https://youtu.be/4GZIBnS2KZ0
And follow us to stay updated: https://www.youtube.com/GlobalOneMedia